AR Holdings Claims Par Pharma Infringed Gout Drug Patent

Law360, New York (April 5, 2012, 3:33 PM EDT) -- Mutual Pharmaceutical Co. affiliate AR Holding Co. Inc. on Wednesday lodged a patent suit against Par Pharmaceutical Inc., alleging the drugmaker has infringed 10 of its patents covering methods for producing gout medication.

AR Holding maintains that Woodcliff Lake, N.J.-based Par has submitted an abbreviated new drug application to the Food and Drug Administration seeking to market a 0.6 mg oral tablet generic version of the brand name gout drug Colcrys, before its patent rights covering the medication expire.  

At issue are U.S. Patents No....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.